As of 26 May 2025, the Health Technology Assessment (HTA) Council has completed the evidence appraisal on the assessment of Japanese encephalitis vaccine for the prevention of Japanese encephalitis among children 9 to 59 months old in high risk areas as defined in the DOH Omnibus Health Guidelines (OHG) for Children under 10 years (2023), continue reading : HTA Council Preliminary Recommendation on Japanese Encephalitis Vaccine (JEV)